Year 2021 / Volume 113 / Number 3
Editorial
Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet)

161-163

DOI: 10.17235/reed.2021.7862/2021

Manuel Romero-Gómez, Javier Ampuero,

Abstract
The name of a disease does not follow any defined protocol and the scientific community’s acceptance of several variants based on the customs of every location is usual. There are examples of prevalent entities with curious naming processes, such as diabetes mellitus. The first word, “diabetes”, comes from the Greek dia (through), be (to go), and tes (factor), while the second word, “mellitus”, comes from Latin melli (honey). As a consequence, diabetes mellitus literally means “the sweet factor that goes through…”, pertaining to an excessive and sweet diuresis. Thus, we could deduce that a definition representing exactly the pathophysiology of the particular disease is not required.
Share Button
New comment
Comments

18/04/2023 0:03:43
RECOVERY OF LOST FUNDS FROM SCAMMER.

Tracking Down Lost Bitcoins and Other Cryptos: Fast without wasting time Contact: Telegram: https://t.me/WizardWebRecovery / Email: wizardwebrecovery@gmail.com, Do you need support of recovery of your lost or stolen bitcoin, trying to obtain cryptocurrency transferred to the wrong wallet address, or believe your wallet has been compromised, get in touch with Wizard Web Recovery Group Hackers . I lost over 412,040 $ after participating in a SINCODE binary scam. The money I fraudulently lost has been recovered thanks to the super work of Wizard Web Recovery Group Hackers . They Working with the new digital software that recovers funds without a twinkle of eyes beep Wizard Web Recovery Group Hackers is trustworthy you can always contact them via
Telegram: https://t.me/WizardWebRecovery
Email: wizardwebrecovery@gmail.com


References
Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. J Hepatol 2015;63:1285-7.
Romero-Gómez M, Wichmann I, Crespo J, et al. Cholangitis. Serum immunological profile in patients with chronic autoimmune cholestasis. Am J Gastroenterol 2004;99:2150-7.
Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
https://www.mscbs.gob.es/estadEstudios/estadisticas/normalizacion/CIE10/UT_MANUAL_DIAG_2016_prov1.pdf
Yuan J, Chen C, Cui J, et al. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell Metab 2019;30:675-688.e7.
Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013;57:601-9.
Ampuero J, Aller R, Gallego-Durán R, et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1260-1270.
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020 Jul;73(1):202-209.
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, et al. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. Gastroenterology 2018;155:443-457.e17.
Gallego-Durán R, Álvarez-Amor L, Gil-Gómez A, et al. Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models. Rev Esp Enferm Dig. 2019 Apr;111(4):301-307.
Ampuero J, Aller R, Gallego-Durán R, et al. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. J Hepatol. 2020 Jul;73(1):17-25.
Martín Mateos R, Allen AM. Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. Rev Esp Enferm Dig 2019;111:253-255.
Gil-Gómez A, Brescia P, Rescigno M, et al. Gut-Liver axis in non-alcoholic fatty liver disease: the impact of the metagenome, end products and the epithelial and vascular barriers. Semin Liver Dis 2021. (in press).
Sánchez-Torrijos Y, Ampuero J, Pérez Palacios D, et al. Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria. Rev Esp Enferm Dig. 2019 Apr;111(4):270-274.
Citation tools
Romero-Gómez M, Ampuero J. Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet). 7862/2021


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 2184 visits.
This article has been downloaded 858 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 03/02/2021

Accepted: 03/02/2021

Online First: 12/02/2021

Published: 08/03/2021

Article Online First time: 9 days

Article editing time: 33 days


Share
This article has been rated by 8 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology